# Naloxone Nasal Spray Pharmacokinetic Study

> **NCT01622504** · PHASE1 · UNKNOWN · sponsor: **Mitovie Pharma Ltd** · enrollment: 6 (estimated)

## Conditions studied

- Opioid Overdose

## Interventions

- **DRUG:** MVP005
- **DRUG:** MVP005
- **DRUG:** Naloxone hydrochloride solution for injection with mucosal atomization device

## Key facts

- **NCT ID:** NCT01622504
- **Lead sponsor:** Mitovie Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01622504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01622504, "Naloxone Nasal Spray Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01622504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*